4-150321257-T-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001364905.1(LRBA):​c.7564A>C​(p.Thr2522Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00698 in 1,612,060 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0072 ( 52 hom. )

Consequence

LRBA
NM_001364905.1 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 0.458

Publications

8 publications found
Variant links:
Genes affected
LRBA (HGNC:1742): (LPS responsive beige-like anchor protein) The protein encoded by this gene is a member of the WDL-BEACH-WD (WBW) gene family. Its expression is induced in B cells and macrophages by bacterial lipopolysaccharides (LPS). The encoded protein associates with protein kinase A and may be involved in leading intracellular vesicles to activated receptor complexes, which aids in the secretion and/or membrane deposition of immune effector molecules. Defects in this gene are associated with the disorder common variable immunodeficiency-8 with autoimmunity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
LRBA Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to LRBA deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008562565).
BP6
Variant 4-150321257-T-G is Benign according to our data. Variant chr4-150321257-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 439869.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00446 (679/152124) while in subpopulation NFE AF = 0.00799 (543/67990). AF 95% confidence interval is 0.00743. There are 0 homozygotes in GnomAd4. There are 294 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 52 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRBANM_001364905.1 linkc.7564A>C p.Thr2522Pro missense_variant Exon 50 of 57 ENST00000651943.2 NP_001351834.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRBAENST00000651943.2 linkc.7564A>C p.Thr2522Pro missense_variant Exon 50 of 57 NM_001364905.1 ENSP00000498582.2

Frequencies

GnomAD3 genomes
AF:
0.00447
AC:
679
AN:
152006
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00164
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00799
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00424
AC:
1051
AN:
248108
AF XY:
0.00408
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.000688
Gnomad ASJ exome
AF:
0.00110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00195
Gnomad NFE exome
AF:
0.00817
Gnomad OTH exome
AF:
0.00430
GnomAD4 exome
AF:
0.00725
AC:
10581
AN:
1459936
Hom.:
52
Cov.:
31
AF XY:
0.00701
AC XY:
5092
AN XY:
726282
show subpopulations
African (AFR)
AF:
0.00135
AC:
45
AN:
33364
American (AMR)
AF:
0.000815
AC:
36
AN:
44168
Ashkenazi Jewish (ASJ)
AF:
0.00180
AC:
47
AN:
26072
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39634
South Asian (SAS)
AF:
0.000151
AC:
13
AN:
85838
European-Finnish (FIN)
AF:
0.00227
AC:
121
AN:
53404
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5754
European-Non Finnish (NFE)
AF:
0.00906
AC:
10065
AN:
1111408
Other (OTH)
AF:
0.00416
AC:
251
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
553
1106
1660
2213
2766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00446
AC:
679
AN:
152124
Hom.:
0
Cov.:
32
AF XY:
0.00395
AC XY:
294
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00164
AC:
68
AN:
41502
American (AMR)
AF:
0.00223
AC:
34
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4812
European-Finnish (FIN)
AF:
0.00189
AC:
20
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00799
AC:
543
AN:
67990
Other (OTH)
AF:
0.00332
AC:
7
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00661
Hom.:
4
Bravo
AF:
0.00487
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00930
AC:
80
ExAC
AF:
0.00463
AC:
562
Asia WGS
AF:
0.000577
AC:
3
AN:
3478
EpiCase
AF:
0.00721
EpiControl
AF:
0.00689

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Combined immunodeficiency due to LRBA deficiency Uncertain:1Benign:4
Oct 04, 2022
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has been reported in the literature in 1 individual with panuveitis (Li 2021 PMID:32707200). This variant is present in the Genome Aggregation Database (Highest reported MAF 0.7% (543/67998) (https://gnomad.broadinstitute.org/variant/4-150321257-T-G?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign (Variation ID:439869). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign.

Nov 15, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 31, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 18, 2020
Genetics and Molecular Pathology, SA Pathology
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, BP4

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Jun 22, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 02, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LRBA: BP4, BS2

LRBA-related disorder Benign:1
May 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
16
DANN
Benign
0.96
DEOGEN2
Benign
0.0
.;T;.;.;.
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.63
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.71
T;T;T;T;T
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.0086
T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.0
.;L;.;.;.
PhyloP100
0.46
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-2.5
N;N;.;N;.
REVEL
Benign
0.24
Sift
Benign
0.14
T;T;.;T;.
Sift4G
Benign
0.22
T;T;.;T;.
Vest4
0.43
ClinPred
0.0060
T
GERP RS
2.3
Varity_R
0.32
gMVP
0.28
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62346982; hg19: chr4-151242409; API